Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SARILUMAB for Prostatic specific antigen: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where SARILUMAB was used for Prostatic specific antigen.

Most Reported Side Effects for SARILUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 5,065 23.6% 662 898
Pain 4,833 22.5% 805 1,089
Arthralgia 4,139 19.3% 867 1,124
Rheumatoid arthritis 3,963 18.4% 894 1,276
Joint swelling 3,951 18.4% 826 1,026
Condition aggravated 3,247 15.1% 787 1,010
Fatigue 3,000 14.0% 821 1,097
Rash 2,912 13.6% 807 1,042
Alopecia 2,660 12.4% 874 1,136
Abdominal discomfort 2,600 12.1% 921 1,217
Hepatic enzyme increased 2,595 12.1% 861 1,129
Systemic lupus erythematosus 2,504 11.7% 942 1,144
Pemphigus 2,445 11.4% 901 1,070
Hand deformity 2,379 11.1% 873 1,047
Glossodynia 2,372 11.0% 868 1,044

Other Indications for SARILUMAB

Rheumatoid arthritis (14,766) Polymyalgia rheumatica (1,963) Product used for unknown indication (1,720) Covid-19 (265) Illness (130) Polyarthritis (103) Psoriatic arthropathy (94) Osteoarthritis (83) Arthritis (79) Psoriasis (75)

Other Drugs Used for Prostatic specific antigen

GOLIMUMAB (848) SECUKINUMAB (100) SIRUKUMAB (47) ADALIMUMAB (43) METHYLPREDNISOLONE (30) APREMILAST (23) METHOTREXATE (18) CERTOLIZUMAB PEGOL (15) HYDROXYCHLOROQUINE (15) TOFACITINIB (11)

Related Pages

SARILUMAB Full Profile All Prostatic specific antigen Drugs SARILUMAB Demographics SARILUMAB Timeline